What to Expect From Veeva Systems' Q3 2027 Earnings Report

With a market cap of $51.5 billion, Veeva Systems Inc. (VEEV) is a leading provider of cloud-based software solutions designed specifically for the life sciences industry, serving customers across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. It offers a comprehensive suite of products through its Commercial Cloud, Data Cloud, and Development Cloud platforms, helping pharmaceutical, biotechnology, and consumer products organizations streamline operations and improve efficiency. 

The Pleasanton, California-based company is slated to announce its fiscal Q3 2027 results soon. Ahead of the event, analysts expect VEEV to report an EPS of $1.68, up 18.3% from $1.42 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in each of the past four quarterly reports.

For fiscal 2027, analysts predict Veeva Systems to post EPS of $6.70, a 14.3% increase from $5.86 in fiscal 2026.

Shares of Veeva Systems have risen 9.2% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 12.2% gain and the State Street Health Care Select Sector SPDR ETF's (XLV) 24.5% return over the same period.

Veeva Systems shares climbed 15.2% following its Q2 2027 results on Aug. 26 after the company reported total revenue up 18% to $928 million, subscription revenue up 16% to $766.8 million, and adjusted EPS of $2.35, with results exceeding guidance across all metrics. Profitability strengthened significantly, as operating income rose 40% to $275 million, net income increased 37% to $273.4 million, and adjusted operating income grew 18% to $415.9 million, reflecting solid execution and growing adoption of its life-sciences software. 

Optimism was further fueled by expanding AI and CRM momentum, including more than 180 Vault CRM customers live, commitments from 12 of the top 20 biopharma companies, and rapid development of Veeva Falcon, alongside improved full-year fiscal 2027 guidance of $3.682 billion - $3.687 billion in revenue and approximately $9.21 in adjusted EPS.

Analysts' consensus rating on VEEV stock is cautiously optimistic, with an overall "Moderate Buy" rating. Among 27 analysts covering the stock, 15 recommend a "Strong Buy,” three have a "Moderate Buy" rating, eight give a "Hold" rating, and one has a "Strong Sell.” AS of writing, the stock is trading above the average analyst price target of $298.40.

On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.